Literature DB >> 3756087

Isolation and characterization of a human colon adenocarcinoma cell line resistant to doxorubicin.

M Grandi, C Geroni, F C Giuliani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3756087      PMCID： PMC2001636          DOI： 10.1038/bjc.1986.206

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  17 in total

1.  Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line.

Authors:  B Drewinko; M M Romsdahl; L Y Yang; M J Ahearn; J M Trujillo
Journal:  Cancer Res       Date:  1976-02       Impact factor: 12.701

2.  Drug resistance in cancer.

Authors:  G A Curt; N J Clendeninn; B A Chabner
Journal:  Cancer Treat Rep       Date:  1984-01

Review 3.  Gene amplification.

Authors:  G R Stark; G M Wahl
Journal:  Annu Rev Biochem       Date:  1984       Impact factor: 23.643

4.  Amplification of specific DNA sequences correlates with multi-drug resistance in Chinese hamster cells.

Authors:  I B Roninson; H T Abelson; D E Housman; N Howell; A Varshavsky
Journal:  Nature       Date:  1984 Jun 14-20       Impact factor: 49.962

5.  Cellular discriminants for a biological classification of human colon carcinoma.

Authors:  B Drewinko; L Y Yang; A Leibovitz; B Barlogie; D Lutz; B Jansson; J J Stragand; J M Trujillo
Journal:  Cancer Res       Date:  1984-10       Impact factor: 12.701

6.  The genetic origin of drug resistance in neoplasms: implications for systemic therapy.

Authors:  J H Goldie; A J Coldman
Journal:  Cancer Res       Date:  1984-09       Impact factor: 12.701

7.  High-level, unstable adriamycin resistance in a Chinese hamster mutant cell line with double minute chromosomes.

Authors:  N Howell; T A Belli; L T Zaczkiewicz; J A Belli
Journal:  Cancer Res       Date:  1984-09       Impact factor: 12.701

Review 8.  Evidence for multidrug-resistant cells in human tumor cell populations.

Authors:  R H Shoemaker; G A Curt; D N Carney
Journal:  Cancer Treat Rep       Date:  1983-10

9.  New type of recovery in HeLa cells exposed to bleomycin.

Authors:  T Miyamoto; M Wakabayashi; T Terasima
Journal:  Br J Cancer       Date:  1984-02       Impact factor: 7.640

10.  Resistance of human glioma to adriamycin in vitro: the role of membrane transport and its circumvention with verapamil.

Authors:  S Merry; C A Fetherston; S B Kaye; R I Freshney; J A Plumb
Journal:  Br J Cancer       Date:  1986-01       Impact factor: 7.640
View more
  23 in total

Review 1.  Susceptibility of human and murine drug-resistant tumor cells to the lytic activity of rIL2-activated lymphocytes (LAK).

Authors:  C Gambacorti-Passerini; L Rivoltini; M Radrizzani; R Supino; M Mariani; G Parmiani
Journal:  Cancer Metastasis Rev       Date:  1988-12       Impact factor: 9.264

2.  Morpholinylanthracyclines: cytotoxicity and antitumor activity of differently modified derivatives.

Authors:  M Ripamonti; L Capolongo; G Melegaro; C Gornati; A Bargiotti; M Caruso; M Grandi; A Suarato
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

3.  Mycobacterium avium-intracellulare contamination of mammalian cell cultures.

Authors:  I H Lelong-Rebel; Y Piemont; M Fabre; G Rebel
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-10-15       Impact factor: 2.416

4.  Flow cytometric analysis of multidrug-resistance-associated antigen (P-glycoprotein) and DNA ploidy in human colon cancer.

Authors:  M Danova; M Giordano; E Erba; S Palmeri; V Candiloro; A Riccardi; G Ucci; G Mazzini; M D'Incalci; E Ascari
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

5.  Phase II study of high-dose epirubicin, lonidamine, alpha 2b interferon in advanced breast cancer.

Authors:  R V Iaffaioli; A Tortoriello; G Facchini; M Santangelo; L Bucci; L Fei; N Di Martino; G Mantovani; F Caponigro
Journal:  Breast Cancer Res Treat       Date:  1995-09       Impact factor: 4.872

6.  The critical size of gold nanoparticles for overcoming P-gp mediated multidrug resistance.

Authors:  Yuqian Jiang; Zheng Wang; Wei Duan; Lingyan Liu; Mahan Si; Xiaoyuan Chen; Chen-Jie Fang
Journal:  Nanoscale       Date:  2020-06-17       Impact factor: 7.790

7.  Micro- and Nanosecond Pulses Used in Doxorubicin Electrochemotherapy in Human Breast and Colon Cancer Cells with Drug Resistance.

Authors:  Nina Rembiałkowska; Vitalij Novickij; Dagmara Baczyńska; Magda Dubińska-Magiera; Jolanta Saczko; Julia Rudno-Rudzińska; Magdalena Maciejewska; Julita Kulbacka
Journal:  Molecules       Date:  2022-03-22       Impact factor: 4.411

8.  Characterization of a clonal human colon adenocarcinoma line intrinsically resistant to doxorubicin.

Authors:  E Dolfini; T Dasdia; G Arancia; A Molinari; A Calcabrini; R J Scheper; M J Flens; M B Gariboldi; E Monti
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Characterisation of a LoVo subline resistant to a benzoyl mustard derivative of distamycin A (FCE 24517).

Authors:  L Capolongo; G Melegaro; M Broggini; N Mongelli; M Grandi
Journal:  Br J Cancer       Date:  1993-11       Impact factor: 7.640

10.  Biological profile of FCE 24517, a novel benzoyl mustard analogue of distamycin A.

Authors:  G Pezzoni; M Grandi; G Biasoli; L Capolongo; D Ballinari; F C Giuliani; B Barbieri; A Pastori; E Pesenti; N Mongelli
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.